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Background: Multiple studies have demonstrated elevated risk of cardiovascular events in patients with renal dysfunction. We hypothesized that 
progressive renal disease would be associated with worsening morphologic changes in the coronary vasculature by intravascular ultrasound (IVUS).
Methods: We utilized the Diabetes Genome Project, a prospective registry of patients undergoing coronary angiography with IVUS, to evaluate 
the relationship between renal dysfunction and atherosclerotic changes in the most diseased 10 mm segment of a single coronary artery. Renal 
parameters included serum creatinine, estimated glomerular filtration rate (GFR), and urinary albumin-to-creatinine ratio (ACR). IVUS was performed 
at the operator’s discretion; only pre-PCI studies were included in this analysis. Continuous motor pullback at 0.5 mm/s was performed after 
intracoronary nitroglycerin infusion per study protocol. Offline plaque measurements included volume of fibrous, fibro-fatty, calcific, and necrotic 
core. Phenotypic characterizations using IVUS-Virtual Histology (VH) included pathologic intimal thickening (PIT), thin cap fibroatheroma (TCFA), and 
fibrocalcific (FC) plaque using standard definitions.
Results: Among 108 patients with complete data available (39% with diabetes), GFR was not associated with any IVUS or VH measurements, but 
weak correlations were noted between serum creatinine and both fibro-fatty plaque volume (r=0.19, p=0.05) and percent PIT (r=0.21, p=0.03). In 
contrast, urinary ACR was more consistently associated with calcium volume (r=0.23, p=0.02), % calcium per plaque (r=0.26, p<0.01), and % FC 
plaque by VH (r=0.27, p<0.01).
Conclusions: Serum creatinine may be linked to intimal thickening and earlier stages of plaque development, but albuminuria appears to have 
a more consistent association with calcific changes in coronary plaques by IVUS-VH morphologic assessment. Since both albuminuria and vascular 
calcification tend to be associated with longstanding exposure to coronary risk factors, these findings suggest that urinary albumin measurement 
may help identify patients at risk of having more advanced coronary atherosclerosis.
